Overview
Paul Volberding is a Hematologist Oncology provider in San Francisco, California. Dr. Volberding has been practicing medicine for over 46 years. His top area of expertise is Kaposi Sarcoma.
His clinical research consists of co-authoring 53 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
University Of California San Francisco
Alain Algazi is a Hematologist Oncology specialist and a Hematologist in San Francisco, California. Dr. Algazi is highly rated in 25 conditions, according to our data. His top areas of expertise are Melanoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Polymorphous Low Grade Adenocarcinoma, and Glioma.
Regents Of The University Of California
Aaron Logan is a Hematologist Oncology specialist and a Hematologist in San Francisco, California. Dr. Logan is highly rated in 36 conditions, according to our data. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Bone Marrow Aspiration, and Bone Marrow Transplant.
Regents Of The University Of California
Hyunseok Kang is a Hematologist Oncology specialist and an Oncologist in San Francisco, California. Dr. Kang is highly rated in 21 conditions, according to our data. His top areas of expertise are Adenoid Cystic Carcinoma, Salivary Gland Tumors, Nasopharyngeal Carcinoma, Thyroid Cancer, and Gastrostomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers